| Detected | Trial | Change |
|---|---|---|
| 2026-06-04 | NCT07007312 Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With… |
Trial sites expanded: 53 -> 71 locations |
| 2026-05-14 | NCT04067336 First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-05-14 | NCT04067336 First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia |
Trial sites reduced: 56 -> 43 locations |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-06-03 | NCT07623616 A Phase 2 Clinical Study of Ziftomenib in Patients With Relapsed or Refractory… | Phase 2 | Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT07007312 | Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With… | Acute Myeloid Leukemia (AML) | Recruiting |
| Phase 2 | |||
| NCT07623616 | A Phase 2 Clinical Study of Ziftomenib in Patients With Relapsed or Refractory… | Acute Myeloid Leukemia (AML) | Recruiting |
| NCT06930352 | Ziftomenib for the Treatment of Patients With NPM1 Mutated or KMT2A Rearranged Acute… | Acute Myeloid Leukemia | Not Yet Recruiting |
| Phase 1/2 | |||
| NCT05848687 | TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II | Lymphoblastic Leukemia | Recruiting |
| NCT04067336 | First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia | Advanced Malignant Neoplasm | Active, Not Recruiting |
| Phase 1 | |||
| NCT06397027 | A Phase I Study Investigating the Combination of the Ziftomenib, Venetoclax and… | Refractory Acute Leukemia | Recruiting |
| NCT06655246 | A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced… | Gastrointestinal Stromal Tumor (GIST) | Recruiting |
| NCT06769490 | Dose Escalation and Expansion of Ziftomenib in Combination With Quizartinib in Acute… | Acute Myeloid Leukemia | Recruiting |
| NCT05735184 | A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With… | Acute Myeloid Leukemia | Recruiting |
| NCT06440135 | Ziftomenib Maintenance Post Allo-HCT | Acute Myeloid Leukemia | Recruiting |
| NCT06001788 | Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory… | AML | Recruiting |
| NCT07355335 | Ziftomenib + Mezigdomide in Adolesc. and Adults w/ R/R AML | KMT2A-rearranged | Not Yet Recruiting |
| NCT07411586 | Phase 1/1b Trial Of Olutasidenib And Ziftomenib For NPM1 And IDH1 Co-Mutated Acute… | Acute Myeloid Leukemia | Not Yet Recruiting |